Clinical Trial Information

A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma

Protocol Number: A052101
Status: Open
Age Group: Adult
Treatment Type: Treatment
Secondary Protocol No.: A052101
Phase: III
NCT ID: NCT05976763

Scope Information

Scope:: National
Disease Site(s):: Non-Hodgkin Lymphoma